Back to search

France· FR:66064046

CEFTAZIDIME VIATRIS ENFANTS ET NOURRISSONS 250 mg, poudre pour solution injectable (IM, IV)

A medicinal product containing ceftazidime pentahydratée, registered in France by VIATRIS SANTE.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedCEFTAZIDIME VIATRIS ENFANTS ET NOURRI…ATC—REGISTER NO.FR:66064046PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CEFTAZIDIME PENTAHYDRATÉE
Manufacturer
VIATRIS SANTE
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400957141707
    5 flacon(s) en verre

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ceftazidime pentahydratée in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ceftazidime pentahydratée products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Ceftazidim Aptapharma, Ceftazidim Hameln
  • Belgium · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
  • Bulgaria · Алфагем, Зидимцеф
  • Cyprus · Alfagem, Cezid
  • Czechia · Altecim, Ceftazidim Aptapharma
  • Germany · Ceftazidim Dr. Eberth, Ceftazidim Hameln
  • Denmark · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
  • Estonia · Altecim, Ceftazidime Fresenius Kabi
  • Spain · Alfagem, Ceftazidima Kabi
  • Finland · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
  • United Kingdom (Northern Ireland) · Ceftazadime, Ceftazidime Cox Pharmaceutical
  • Greece · Alfagem, Ceftaridem
  • Croatia · Altecim, Cefaz
  • Hungary · Ceftazidim Aptapharma, Ceftazidim Kabi
  • Ireland · Ceftazidime Hameln, Ceftazidime Hikma Farmacêutica
  • Iceland · Ceftazidim Fresenius Kabi, Ceftazidima Normon
  • Italy · Ceftazidima Almus, Ceftazidima Astro-Pharma
  • Lithuania · Biotum, Ceftazidime Kabi
  • Luxembourg · Ceftazidim Fresenius Kabi, Glazidim
  • Latvia · Ceftazidime Fresenius Kabi, Ceftazidime Mip
  • Malta · Alfagem, Ceftazidima Fresenius
  • Netherlands · Ceftazidim (Im/Iv) Mip, Ceftazidim (Iv) Mip
  • Norway · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
  • Poland · Biotum, Ceftazidim Aptapharma
  • Portugal · Alfagem, Ceftazidima Accord
  • Romania · Alfagem, Ceftamil
  • Sweden · Ceftazidim Hameln, Fortum
  • Slovenia · Ceftazidim Aptapharma, Ceftazidim Kabi
  • Slovakia · Ceftazidim Ash, Ceftazidim Hameln

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d794c18b-a8c3-4b43-a409-77b2457d662f
GET /v1/drugs/d794c18b-a8c3-4b43-a409-77b2457d662f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66064046",
  "date_amm": "2007-10-17",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CEFTAZIDIME PENTAHYDRATÉE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour solution injectable",
  "voies_administration": "intramusculaire;intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about ceftazidime pentahydratée.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.